Tag Archives: Exchanges in India

INOX kicks-off Multiplex at Gorakhpur in Uttar Pradesh

VADODARA (BARODA) | MUMBAI | RAJKOT – INOX Leisure Ltd has kicked-off multiplex at Gorakhpur in Uttar Pradesh, the company statement filed with the Indian Exchanges on Monday said. The Company has commenced the Commercial Operations of a Multiplex Cinema Theatre taken on Lease basis, located at INOX Gorakhpur City Mall, 2nd F1oor, 6, Civil

Zydus Cadila gets US FDA nod to market osteoporosis, ortho treatment drug

MUMBAI | AHMEDABAD | RAJKOT – Dr Pankaj Patel led and Ahmedabad headquartered Zydus Cadila Group (Cadila Healthcare Ltd) has received final approval from the US regulators to market ortho treatment medicine, the company said in a press release submitted to the Indian Bourses, today. Zydus Cadila has received the final approval from the USFDA

Zydus Cadila gets US FDA nod to market tablets for diabetic care

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Tuesday, Dr Pankaj Patel led Zydus Cadila group (Cadila Healthcare Ltd.) said of having got approval from US FDA (Food & Drugs Administration) to market Sitagliptin Tablets in dosage value of 25 mg (milligram), 50 mg and 100 mg.

Welspun Enterprises’ updates NHAI announcement on Ganga Bridge project

VERSAMEDI-ANJAAR (KUTCH-BHUJ) | MUMBAI | RAJKOT – In a regulatory filing submitted to the exchanges in India on Monday, Welspun Enterprises Ltd said of National Highways Authority of India (NHAI) having declared the appointed date for the Six laning of Aunta-Simaria (Ganga Bridge with approach roads). National Highways Authority of India (“NHAI”) has declared the

Zydus Cadila gets USFDA nod to market anti-viral drug

AHMEDABAD | MUMBAI | RAJKOT – Dr Pankaj Patel led Zydus Cadila Group got US FDA (Food and Drugs Administration) nod to market anti-viral drug Acyclovir Sodium Injection in composition of 500 mg and 1,000 mg, Cadila Healthcare Ltd said today, in a press release submitted to the Exchanges in India. Zydus Cadila has received

JMC Projects board nods 1.5 billion rupees fund-raising on private placement basis

AHMEDABAD | MUMBAI | RAJKOT – Infra Projects & Construction arm of Kalptaru Group, JMC Projects (India) Ltd board decides to raise 1.5 billion (~150 crore) rupees on private placement basis, by issuing 1,500 non-convertible debentures each valued at 1 million (~10 lakh) rupees, the company said in regulatory filing submitted to the Exchanges in

Inox Leisure opens Multiplex at Coimbatore (Tamilnadu)

VADODARA (BARODA) | MUMBAI | RAJKOT – Inox Leisure Ltd said in regulatory filing submitted to the exchanges in India on Monday – August 20, 2018, regarding multiplex cinema theatre made operational at Coimbatore, Tamilnadu. The Company has commenced the Commercial Operations of a Multiplex Cinema Theatre taken on Leave and License basis, located at INOX Leisure

Ratnamani Metal bags 1.55 billion rupees pipe supply orders from Oil-Gas Sector

AHMEDABAD | MUMBAI | RAJKOT – Ratnamani Metals & Tubes Ltd said in regulatory filing submitted to the exchanges in India on Saturday, August 18, 2018 regarding the Company having bagged two orders for supply of pipes from oil & gas sector pegged at 1.55 billion rupees. The company has has received two new orders for

INOX Leisure adds 2 screens to Multiplex in Pune (Maharashtra), discontinues multiplex at Kota (Rajasthan)

VADODARA (BARODA) | MUMBAI | RAJKOT – Inox Leisure Ltd has added 2 new screens to an ongoing operational multiplex at Pune in Maharashtra and has discontinued Multiplex at Kota in Rajasthan, the company said in regulatory filing submitted to the Exchanges in India on Wednesday. The Company has commenced the Commercial Operations of two

Zydus Cadila gets USFDA nod to market anti-bacterial drug to cure respiratory, skin, ear and sexually transmitted disease

AHMEDABAD | MUMBAI | RAJKOT – Zydus Cadila (Cadila Healthcare Ltd) has received the final approval from the USFDA to market Azithromycin for Oral Suspension USP (US RLD – Zithromax), 100 mg/5 mL and 200 mg/5 mL, the company said in the press release submitted to Exchanges in India on Wednesday. This medication contains Azithromycin, a

Zydus Cadila gets USFDA nod to market impotence treatment drug

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the exchanges in India, Cadila Healthcare Ltd said of having got tentative approval to market drug to cure erectile dysfunction. Zydus Cadila has received the tentative approval from the USFDA to market Vardenafil Hydrochloride Tablets (US RLD-Levitra) in the strengths of 2.5 mg, 5

Adani Ports inks long term regasification pact with GAIL (India) Ltd. for Dhamra LNG terminal

AHMEDABAD | MUMBAI | RAJKOT – Adani Ports and Special Economic Zone (APSEZ) Ltd – India’s leading port infrastructure developer and part of the Adani Group, today said it had signed a long term agreement with GAIL (India) Ltd, the state run gas company, to provide Liquefied Natural Gas (LNG) regasification services on a use or pay basis, at

Inox commences 3 screen 567 seats multiplex at Sapphire 83 Mall in Gurugram (Gurgaon)

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory filing submitted to the exchanges in India on Tuesday, Inox Leisure said of having commenced commercial operations of a Multiplex at a shopping mall at Gurugram (Gurgaon) in Haryana state. The Company has commenced the Commercial Operations of a Multiplex Cinema Theatre located at INOX

JMC Projects bags 5.56 billion rupees infra orders from Bihar, Orissa

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to the Stock Exchanges in India, JMC Projects (India) Ltd (JMC), said of having bagged new orders worth 5.56 billion (~556 crore) rupees. The new order comprises of EPC (Engineering, Procurement and Construction) project for laying of water pipeline in Orissa for 2.83 billion

Zydus Cadila gets USFDA nod to market injection to cure liver injury

AHMEDABAD | MUMBAI | RAJKOT – Cadila Healthcare Ltd in a regulatory filing submitted to the Exchanges in India said of having got US FDA (Food & Drug Administration) nod to market an injection to cure liver injury. Zydus Cadila has received the final approval from the USFDA to market Acetylcysteine Injection (US RLD –

Zydus Cadila cracks one more USFDA approval to cure High Blood Pressure

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to exchanges in India on Friday, Cadila Healthcare Ltd said of getting one more approval from US FDA (Food & Drug Administration) to market tablets to cure high blood pressure and prevent heart failure. Zydus Cadila has received the final approval from the USFDA